# Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-first-line-treatment-and-overall-survival-in-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amy P. Abernethy,Ashwini Arunachalam,Thomas Burke,Caroline McKay,Xiting Cao,Rachael Sorg,David P. Carbone |
| Citations | 95 |
| DOI | 10.1371/journal.pone.0178420 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0178420&type=printable |
| OpenAlex ID | https://openalex.org/W2658569466 |
| PMID | 28644837 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Caroline McKay](https://scholariq.org/researchers/caroline-mckay/)

## Paper journal

- [PLoS ONE](https://scholariq.org/journals/plos-one/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.